Chirotechnology: Designing economic chiral syntheses

Journal of Chemical Technology and Biotechnology

Volumn 67, Issue 1, 1996, Pages 1-14

  Sheldon, R A ^a  

^a DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

Asymmetric epoxidation; Asymmetric synthesis; Enzymatic ammoniolysis; Kinetic resolution; Resolution via crystallization

Indexed keywords

BIOSYNTHESIS; COST EFFECTIVENESS; CRYSTALLIZATION; DRUG PRODUCTS; MOLECULES;

ASYMMETRIC EPOXIDATION; ASYMMETRIC SYNTHESIS; BIOLOGICAL ACTIVITY; CHIRAL PHARMACEUTICALS; CHIRAL SYNTHESIS; CHIRALITY; CHIROTECHNOLOGY; ENANTIOMERS; ENZYMATIC AMMONIOLYSIS; ENZYMATIC KINETIC RESOLUTION;

BIOTECHNOLOGY;

AMOXICILLIN; AMPICILLIN; CAPTOPRIL; DILTIAZEM; IBUPROFEN; NAPROXEN;

BIOTECHNOLOGY; CATALYSIS; CHEMICAL INDUSTRY; CHIRALITY; CRYSTALLIZATION; DRUG MANUFACTURE; ENANTIOMER; ENZYME KINETICS; METHODOLOGY; RACEMIC MIXTURE; REVIEW;

EID: 0030249955     PISSN: 02682575     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-4660(199609)67:1<1::aid-jctb531>3.3.co;2-c     Document Type: Review

References (42)

1. Borman, S., Chirality emerges as a key issue in pharmaceutical research. Chem. Eng. News, 9 July (1990) 9-14.
2. Stinson, S. C., Chiral drugs. Chem. Eng. News, 28 September (1992) 46-80; 27 September (1993) 38-65; 19 September (1994) 38-72.
3. Stinson, S. C., Chiral drugs. Chem. Eng. News, 28 September (1992) 46-80; 27 September (1993) 38-65; 19 September (1994) 38-72.
4. Stinson, S. C., Chiral drugs. Chem. Eng. News, 28 September (1992) 46-80; 27 September (1993) 38-65; 19 September (1994) 38-72.
5. Testa, B. & Trager, W. F., Racemates versus enantiomers in drug development: dogmatism or pragmatism? Chirality, 2 (1990) 129-33.
6. Sheldon, R. A., Chirotechnology. Marcel Dekker, New York, 1993.
7. Collins, A. N., Sheldrake, G. N. & Crosby, J., Chirality in Industry. Wiley, New York, 1992.
8. Sheldon, R. A., Industrial synthesis of optically active compounds. Chem. Ind. (London), 2 April (1990) 212-19.
9. Sheldon, R. A., The industrial synthesis of pure enantiomers. Drug Inform. J., 24 (1990) 129-39.
10. Takahashi, S., Microbial production of D-p-hydroxyphenylglycine. In Progress in Industrial Microbiology, Vol. 24, eds K. Aida, I. Chibata, K. Nakayama, T. Takanami & H. Yamada. Elsevier, Amsterdam, 1986, pp. 269-79.
11. Olivieri, R., Fascetti, E., Angelini, L. & Degen, L., Microbial transformation of racemic hydantoins to D-amino acids. Biotechnol. Bioeng., 23 (1985) 2173-83.
12. Bruggink, A., Where chemistry and fermentation meet, lecture presented at the CPhI Conference on Pharmaceutical Ingredients and Intermediates, Paris, September, 1994.
13. Lodewijk, E., Evolvement of naproxen production over a twenty year time frame, lecture presented at the Second International Symposium on Technologies for the Production of Enantiomerically Pure Chemicals, Naples, Florida, March 14-17, 1995.
14. Giordano, C. & Castaldi, G., A. stereoconvergent strategy for the synthesis of enantiomerically pure (R)-(-) and (S)-(+)-2-6-methoxy-2-naphthyl)-propanoic acid (naproxen). Tetrahedron, 45 (1990) 4243-52.
15. Battistel, E., Bianchi, D., Cesti, P. & Pina, C., Enzymatic resolution of (S)-(+)-naproxen in a continuous reactor. Biotechnol. Bioeng., 38 (1991) 659-64.
16. Mutsaers, J. H. G. M. & Kooreman, H. J., Preparation of optically pure 2-aryl- and 2-aryloxypropionates by selective enzymatic hydrolysis. Red. Trav. Chim. Pays-Bas, 110 (1991) 185-8.
17. Chan, A. S. C., A new route to important chiral drugs. CHEMTECH, March (1993) 46-51.
18. Ohta, T., Takaya, H., Kitamura, M., Nagai, K. & Noyori, R., Asymmetric hydrogenation of unsaturated carboxylic acids catalyzed by BINAP-ruthenium(II) complexes. J. Org. Chem., 52 (1987) 3174-6.
19. Babin, J. E. & Whitaker, G. T., Preparation of catalyst ligands for asymmetric synthesis, WO 93,03,839 (1993) to Union Carbide, CA, 119 (1993) 159872h.
20. Davenport, K. G., The BHC ibuprofen process: innovation in pharmaceuticals processing, lecture presented at the Second International Symposium on Technologies for the Production of Enantiometrically Pure Chemicals, Naples, Florida, March 14-17, 1995.
21. Sheldon, R. A., Consider the environmental quotient. CHEMTECH, March (1994) 38-47.
22. Takagi, M., Shirokaze, J. I., Oishi, K., Otsubo, K., Yamamoto, K., Yoshida, N. & Fujimatsu, I., Production of (S)-ibuprofen with high optical yield from a nitrile compound by cells immobilized on cellulose porous beads. J. Ferment Bioeng., 78 (1994) 191-3.
23. Sheldon, R. A., Zeegers, H. J. M., Houbiers, J. P. M. & Hulshof, L. A., The synthesis of angiotensin converting enzyme (ACE) inhibitors. Chemistry Today, May (1991) 35-47.
24. Ohashi, T. & Hasegawa, J., New preparative methods for optically active β-hydroxycarboxylic acids. In Chirality in Industry, eds A. N. Collins, G. N. Sheldrake & J. Crosby. Wiley, New York, 1992, pp. 249-67.
25. Ohashi, T. & Hasegawa, J., D-(-)-β-Hydroxycarboxylic acids as raw materials for captopril and β-lactams. In Chirality in Industry, eds A. N. Collins, G. N. Sheldrake & J. Crosby. Wiley, New York, 1992, pp. 269-78.
26. Sakimae, A., Hosoi, A., Kobayashi, E., Ohsuga, N., Numazawa, R., Watanabe, I. & Ohnishi, H., Screening of microorganisms producing D-β-acetylthioisobutyric acid from methyl DL-β-acetylthioisobutyrate. Biosci. Biotech. Biochem., 56 (1992) 1252-6.
27. Hulshof, L. & Roskam, J. H., Phenylglycidate stereoisomers, conversion products thereof with e.g. 2-nitrothiophenol and preparation of diltiazem. Eur. Pat. Appl., 0343714 (1989) to Stamicarbon.
28. Matsumae, H., Furui, M., Shibatani, T. & Tosa, T., Production of optically active 3-phenylglycidic acid ester by the lipase from Serratia marcescens on a hollow-fibre membrane reactor. J. Ferment. Bioeng., 78 (1994) 59-63.
29. Matsumae, H., Furui, M. & Shibatani, T., Lipase-catalyzed asymmetric hydrolysis of 3-phenyglycidic acid ester, the key intermediate in the synthesis of diltiazem hydrochloride. J. Ferment. Bioeng., 75 (1993) 93-8.
30. Kanerva, L. T. & Sundholm, O., Lipase catalysis in the resolution of racemic intermediates of diltiazem synthesis in organic solvents. J. Chem. Soc. Perkin Trans. I (1993) 1385-9.
31. Jacobsen, E. N., Deng, L., Furukawa, Y. & Martinez, L. E., Enantioselective catalytic epoxidation of cinnamate esters. Tetrahedron, 50 (1994) 4323-34.
32. Watson, K. G., Fung, Y. M., Gredley, M., Bird, G. J., Jackson, R., Gountzos, H. & Mathews, B. R., Asymmetric synthesis of (+) diltiazem hydrochloride. J. Chem. Soc. Chem. Commun., (1990) 1018-9.
33. Kolb, H. C., Van Nieuwenhze, M. S. & Sharpless, K. B., Catalytic asymmetric dihydroxylation. Chem. Rev., 94 (1994) 2483-547.
34. Palmer, J. T., 2-Hydroxy-3-(4-methoxyphenyl)-3-(2-aminophenylthio) propionic acid 8′-phenylmenthyl ester, especially for diltiazem. Eur. Pat. Appl., 0342904 (1989) to Marion Labs; Japanese Pat. Appl. 63-52333 (1988) to Tanabe.
35. Stinson, S., AIDs drug from Merck attaining low-cost production may be vital. Chem. Eng. News, May 16 (1994) 6-7.
36. Jacobsen, E. N., Asymmetric catalytic epoxidation of unfunctionalized olefins. In Catalytic Asymmetric Synthesis, ed. I. Ojima. VCH Press, New York, 1993, pp. 159-202.
37. Ader, U. & Schneider, M. P., Enzyme assisted preparation of enantiomerically pure β-adrenergic blockers III. Optically active chlorohydrin derivatives and their conversion. Tet. Asymm., 3 (1992) 521-4.
38. de Zoete, M. C., Van Rantwijk, F. & Sheldon, R. A., Lipase-catalyzed transformations with unnatural acyl acceptors. Catalysis Today, 22 (1994) 563-90.
39. de Zoete, M. C., Kock-van Dalen, A. C., van Rantwijk, F. & Sheldon, R. A., Ester ammoniolysis: a new enzymatic reaction. J. Chem. Soc. Chem. Commun., (1993) 1831-2.
40. de Zoete, M. C., Kock-van Dalen, A. C., van Rantwijk, F. & Sheldon, R. A., A new enzymatic reaction : enzyme catalyzed ammoniolysis of carboxylic esters. Biocatalysis, 10 (1994) 307-16.
41. de Zoete, M. C., Ouwehand, A. A., van Rantwijk, F. & Sheldon, R. A., Enzymatic ammoniolysis of amino acid derivatives. Recl. Trav. Chim. Pays-Bas, 114 (1995) 171-4.
42. Ariëns, E. J., Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology. Eur. J. Clin. Pharmacol., 26 (1984) 663-8.